Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Williams

Showing results (391-400 of 536) with videos related to

Pageof 54
Sort By:
The Journal of Investigative Dermatology|August 30, 2019
A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2Mohan Liu, Jacob Degner, Robert W Georgantas, et al.
Lancet (London, England)|July 9, 2019
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trialKristian Reich, Melinda Gooderham, Diamant Thaçi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2005
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patientsSaurabh Chandra, Orna Levran, Ingrid Jurickova, et al.
The Journal of Rheumatology|October 13, 2009
Fibromyalgia syndrome module at OMERACT 9: domain constructPhilip Mease, Lesley M Arnold, Ernest H Choy, et al.
Journal of the American Academy of Dermatology|October 11, 2017
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trialBoni E Elewski, Martin M Okun, Kim Papp, et al.
The Journal of Rheumatology|October 13, 2009
Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndromeErnest H Choy, Lesley M Arnold, Daniel J Clauw, et al.
Translational Behavioral Medicine|February 22, 2022
If you personalize it, will they use it?: Self-reported and observed use of a tailored, internet-based pain self-management programLillian Reuman, Chelsey Solar, R Ross MacLean, et al.
Experimental Hematology|September 16, 2017
Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectorsMaria E Alonso-Ferrero, Niek P van Til, Kerol Bartolovic, et al.
The Journal of Urology|December 3, 2014
Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP studyJohn N Krieger, Alisa J Stephens, J Richard Landis, et al.
Scientific Reports|May 24, 2023
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastomaLiyen K Kan, Matthew Drill, Padmakrishnan C Jayakrishnan, et al.
Pageof 54

Showing results (391-400 of 536) with videos related to

Sort By:
Pageof 54
The Journal of Investigative Dermatology|August 30, 2019
A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2Mohan Liu, Jacob Degner, Robert W Georgantas, et al.
Lancet (London, England)|July 9, 2019
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trialKristian Reich, Melinda Gooderham, Diamant Thaçi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2005
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patientsSaurabh Chandra, Orna Levran, Ingrid Jurickova, et al.
The Journal of Rheumatology|October 13, 2009
Fibromyalgia syndrome module at OMERACT 9: domain constructPhilip Mease, Lesley M Arnold, Ernest H Choy, et al.
Journal of the American Academy of Dermatology|October 11, 2017
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trialBoni E Elewski, Martin M Okun, Kim Papp, et al.
The Journal of Rheumatology|October 13, 2009
Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndromeErnest H Choy, Lesley M Arnold, Daniel J Clauw, et al.
Translational Behavioral Medicine|February 22, 2022
If you personalize it, will they use it?: Self-reported and observed use of a tailored, internet-based pain self-management programLillian Reuman, Chelsey Solar, R Ross MacLean, et al.
Experimental Hematology|September 16, 2017
Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectorsMaria E Alonso-Ferrero, Niek P van Til, Kerol Bartolovic, et al.
The Journal of Urology|December 3, 2014
Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP studyJohn N Krieger, Alisa J Stephens, J Richard Landis, et al.
Scientific Reports|May 24, 2023
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastomaLiyen K Kan, Matthew Drill, Padmakrishnan C Jayakrishnan, et al.
Pageof 54